Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fokus Mining Intersects 10 Metres Grading 10.06 G/T At The Galloway Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Healthcare Biotechnology
Quest PharmaTech Inc. is a Canadian biopharmaceutical company. The Company is developing products to improve the quality of life. It is developing the proprietary, MAb-AR9.6, targeting MUC16 as a diagnostic agent for cancer. MAb-AR9.6 is licensed from the University of Nebraska Medical Centre and is in late preclinical stage development. The Company has a 42.5% ownership interest in OncoQuest... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:QPT)

Quest Receives Cash Dividend Payment from OncoQuest

Canada NewsWire January 30, 2024

Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

Canada NewsWire January 23, 2024

Quest PharmaTech Provides Corporate Update

Canada NewsWire September 13, 2023

Quest PharmaTech Announces Results from AGM

Canada NewsWire July 14, 2023

Quest PharmaTech Provides Product Development Update

Canada NewsWire July 10, 2023

Quest PharmaTech Provides Corporate Update

Canada NewsWire June 9, 2023

Canadian Investment Regulatory Organization Trade Resumption - QPT

Canada NewsWire June 7, 2023

Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.

Canada NewsWire June 6, 2023

Canadian Investment Regulatory Organization Trading Halt - QPT

Canada NewsWire June 6, 2023
View More News ››

Opinion & Analysis (TSXV:QPT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:QPT)

RE:RE:RE:RE:RE:Interesting

In addition to the above, I highly doubt Shenzhen Hepalink a 15% owner of QPT will let Canaribio run away with Oregovomab unchallenged...
G1945V - March 19, 2024

RE:RE:RE:RE:Interesting

Let the Clinical Trial play out. Canaribio is on the hook no matter what. Let's hope Phase 111 succeeds. If it doesn't...
G1945V - March 18, 2024

RE:RE:RE:Interesting

With $300 million deal that was done wrong denying QPT the cash for their 45% interest in oregovomab and that same 45% interest in...
TrickyGame - March 18, 2024

RE:RE:Interesting

Not sure if tQPT have the funds for a lenghty legal battle with Canaribio in court. QPT have little revenues. Hoping that Canaribio will...
ARIMA11 - March 18, 2024

RE:Interesting

I believe QPT has said they are willing to go to court to protect thier 45% interest in oregovomab. At best they end up getting...
TrickyGame - March 18, 2024

RE:Interesting

https://www.hepalink.com/en/MedicineBusiness/index.aspx https://www.hepalink.com/OncoVent/en/oreg.html Worth keeping an eye on this...
ARIMA11 - March 17, 2024
View more Bullboard ››

GMV Minerals Inc

GMV Minerals Inc

GMV Minerals Inc. is a junior gold development company. The Company is focused on developing precious metal assets in Arizona ...
View More »